SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist

Overview of attention for article published in Frontiers in Nephrology, April 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 13,182 followers.

SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist https://t.co/Okcy1WMKvn https://t.co/7cBHFZOylp

🔎 Why not check out one of the manuscripts published in our journal? 👇 You can find and read the review article here https://t.co/8eB5eItL66 https://t.co/7v7WBzXUCu

New Research: New Research: SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist https://t.co/jF4CuDDEgW #Nephrology

RT @ASPNeph: SGLT2 INHIBITORS: A BROAD IMPACT THERAPEUTIC OPTION FOR THE NEPHROLOGIST https://t.co/Lt17a8Qw9K @FrontMedicine

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.